Evidence map›Paper›PMID 31771571›Full record

ArticleBMC health services research2019

Comparative evaluation of drug information leaflets for non-steroidal anti-inflammatory drugs in Palestine: local versus imported products.

Dina A Arandy, Maysa W Abu-Hashia, Bahaa M Al-Hroub, Sandra A Qatmosh, Amer A Koni, Baraa G Qeeno, Samah W Al-Jabi, Sa'ed H Zyoud

Abstract readComparative StudyEvaluation Study
In one paragraph

Article in BMC health services research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Dina A ArandyPharmD program, College of Medicine and Health Sciences, An-Najah National University, Nablus, 44839, Palestine.
Maysa W Abu-HashiaPharmD program, College of Medicine and Health Sciences, An-Najah National University, Nablus, 44839, Palestine.
Bahaa M Al-HroubPharmD program, College of Medicine and Health Sciences, An-Najah National University, Nablus, 44839, Palestine.
Sandra A QatmoshPharmD program, College of Medicine and Health Sciences, An-Najah National University, Nablus, 44839, Palestine.
Amer A KoniPharmD program, College of Medicine and Health Sciences, An-Najah National University, Nablus, 44839, Palestine.
Baraa G QeenoPharmD program, College of Medicine and Health Sciences, An-Najah National University, Nablus, 44839, Palestine.
Samah W Al-JabiDepartment of Clinical and Community Pharmacy, College of Medicine and Health Sciences, An-Najah National University, Nablus, 44839, Palestine.
Sa'ed H ZyoudDepartment of Clinical and Community Pharmacy, College of Medicine and Health Sciences, An-Najah National University, Nablus, 44839, Palestine. saedzyoud@yahoo.com.ORCID http://orcid.org/0000-0002-7369-2058

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDrug information leaflets (DILs) are written for patients and health care providers to show how to use the medications safely and effectively, in order to reach the required therapeutics outcomes. This comparative study was conducted to evaluate various DILs of non-steroidal anti-inflammatory drugs (NSAIDs) that are produced in Palestine, along with their imported equivalents.

methodsThirty-five DILs of NSAIDs were analyzed and evaluated in a cross-sectional comparative study. Thirty-one statements were obtained from literature and used; evaluation was performed on basis of both any presence or absence of these statements in the leaflets. 23 of the 31 statements that were available in both local and imported DILs were also evaluated in terms of total word-counts: the median (interquartile range) word-count for each statement was determined separately for the two groups and then compared. For the remaining 8 statements, this was not performed,either because they were not present in any leaflet, or because counting the number of words would not be meaningful.

resultsA total of 35 DILs for nine different active ingredients of NSAIDs were analyzed. In 97% of leaflets, "Instructions to convert medication into liquid forms" were missing and 94% did not provide any information about "Pharmacokinetics". 83% of DILs provided no information about "Mechanism of action" and 74% did not mention any reliable references. 66% of the analyzed inserts did not include any instruction about the possibility of a tablet splitting. And in 63%, the "Date of last revision" was missing. Further, "Duration of using" and "Inactive ingredients" were not found in 51% of leaflets. In terms of word-count, the related sections of the 23 selected criteria were expressed with more words by imported leaflets compared with the local ones, significant differences were found in 12 categories, the highest significance of > 42.4-fold difference was found in "Geriatric considerations" category whereas 1.4-fold difference was found in "Shelf life," being the lowest one.

conclusionsThis study shows that local products provide less information than imported products, so we recommend that appropriate measurements be taken by both Palestinian authorities and manufacturers to improve both quantity and quality of local DILs.

Indexed as

PamphletsAnti-Inflammatory Agents, Non-SteroidalCross-Sectional StudiesHumansMiddle EastPatient Education as TopicProduct PackagingPublicationsAnti-Inflammatory Agents, Non-SteroidalNon-steroidal anti-inflammatory drugsPalestinePatient package insert

Identifiers

PMID31771571
PMCPMC6880552

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.